Microbiologist at Acadia Pharmaceuticals

Sacramento, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Expertise in developing and validating microbiological test methods in accordance with compendial and regulatory requirements
Knowledge of current Good Manufacturing Practices (cGMP), regulatory standards, and company policies
Ability to maintain accurate and detailed records, prepare and review reports, protocols, and SOPs
Proficiency in microbiological testing techniques, including microbial enumeration, identification, and antimicrobial effectiveness testing
Strong collaboration skills to work with cross-functional teams on project objectives, timelines, and process improvements
Mentoring and training abilities to guide microbiology staff and foster continuous learning

Responsibilities

Conduct microbiological testing of primary packaging materials, raw materials, in-process samples, finished products, and environmental samples
Develop and validate microbiological test methods
Maintain accurate and detailed records of all microbiological testing and analysis; prepare and review reports, protocols, and SOPs
Ensure compliance with regulatory standards, cGMP requirements, and company policies; participate in internal and external audits
Manage microbiology-related projects, including method transfers, validations, and investigations
Collaborate with cross-functional teams to meet project objectives and timelines, and identify process improvements
Mentor and provide training and guidance to microbiology staff

Skills

GMP

Microbiology

Quality Control

Sampling

Testing

Documentation

Regulatory Compliance

Microbial Testing

Pharmaceutical Manufacturing

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free